Medtronic Plc (MDT): Carol A Surface , SVP, Chief HR Officer of Medtronic Plc sold 9,787 shares on Jul 6, 2016. The Insider selling transaction was reported by the company on Jul 8, 2016 to the Securities and Exchange Commission. The shares were sold at $87.08 per share for a total value of $852,272.50 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 6, 2016, Bryan C Hanson (EVP, President, MITG) sold 15,272 shares at $87.11 per share price.On Jun 7, 2016, Richard Kuntz (SrVP & Chief Scien, Clin, Reg) sold 49,905 shares at $82.60 per share price.Also, On Jun 3, 2016, Hoedt Rob Ten (EVP & President EMEAC) sold 12,100 shares at $80.54 per share price.On Mar 22, 2016, Shirley A Jackson (director) sold 1,238 shares at $75.60 per share price.
Medtronic PLC: On Tuesday, Jul 6, 2016 heightened volatility was witnessed in Medtronic PLC which led to swings in the share price. The shares opened for trading at $86.82 and hit $87.99 on the upside , eventually ending the session at $87.05, with a gain of 0.02% or 0.02 points. The heightened volatility saw the trading volume jump to 56,01,081 shares. The 52-week high of the share price is $87.99 and the company has a market cap of $121,411 M . The 52-week low of the share price is at $55.54.
Company has been under the radar of several Street Analysts.Medtronic PLC is Initiated by Guggenheim to Neutral. The Rating was issued on Jun 9, 2016.Medtronic PLC is Reiterated by Needham to Buy and the brokerage firm has raised the Price Target to $ 93 from a previous price target of $90 .The Rating was issued on Jun 7, 2016.Medtronic PLC is Reiterated by Wedbush to Neutral and the brokerage firm has raised the Price Target to $ 82 from a previous price target of $79 .The Rating was issued on Jun 1, 2016.Medtronic PLC is Initiated by Sun Trust Rbsn Humphrey to Buy and the brokerage firm has set the Price Target at $93. The Rating was issued on Apr 25, 2016.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops manufactures and markets its medical devices and technologies to hospitals physicians clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group Minimally Invasive Technologies Group Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine Neuromodulation Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic Inc. is a subsidiary of the Company.